1. Home
  2. SLNO vs AQN Comparison

SLNO vs AQN Comparison

Compare SLNO & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • AQN
  • Stock Information
  • Founded
  • SLNO 1999
  • AQN 1988
  • Country
  • SLNO United States
  • AQN Canada
  • Employees
  • SLNO N/A
  • AQN N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AQN Electric Utilities: Central
  • Sector
  • SLNO Health Care
  • AQN Utilities
  • Exchange
  • SLNO Nasdaq
  • AQN Nasdaq
  • Market Cap
  • SLNO 3.8B
  • AQN 4.4B
  • IPO Year
  • SLNO 2014
  • AQN 1998
  • Fundamental
  • Price
  • SLNO $86.00
  • AQN $5.90
  • Analyst Decision
  • SLNO Strong Buy
  • AQN Hold
  • Analyst Count
  • SLNO 9
  • AQN 8
  • Target Price
  • SLNO $105.11
  • AQN $6.28
  • AVG Volume (30 Days)
  • SLNO 1.5M
  • AQN 5.7M
  • Earning Date
  • SLNO 08-06-2025
  • AQN 08-08-2025
  • Dividend Yield
  • SLNO N/A
  • AQN 4.41%
  • EPS Growth
  • SLNO N/A
  • AQN N/A
  • EPS
  • SLNO N/A
  • AQN N/A
  • Revenue
  • SLNO N/A
  • AQN $2,365,738,000.00
  • Revenue This Year
  • SLNO N/A
  • AQN $4.68
  • Revenue Next Year
  • SLNO $506.77
  • AQN $3.79
  • P/E Ratio
  • SLNO N/A
  • AQN N/A
  • Revenue Growth
  • SLNO N/A
  • AQN 4.15
  • 52 Week Low
  • SLNO $41.50
  • AQN $4.19
  • 52 Week High
  • SLNO $90.32
  • AQN $6.30
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 54.38
  • AQN 51.46
  • Support Level
  • SLNO $83.53
  • AQN $5.81
  • Resistance Level
  • SLNO $89.12
  • AQN $6.03
  • Average True Range (ATR)
  • SLNO 2.65
  • AQN 0.10
  • MACD
  • SLNO -0.34
  • AQN -0.01
  • Stochastic Oscillator
  • SLNO 56.91
  • AQN 26.47

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.

Share on Social Networks: